Technical Analysis: Based on the latest technical indicators, ABBV shows strong bullish momentum:
Price Target Analysis: Using Fibonacci projections and technical resistance levels:
News Sentiment Impact: Recent positive catalysts:
Price Prediction for Next Week: Based on technical setup and positive fundamentals:
Trading Recommendation: BUY
The stock shows strong momentum with solid fundamentals and positive technical setup. The risk/reward ratio favors longs with defined risk below recent support levels.
The price of ABBV is predicted to go up 4.06%, based on the high correlation periods with UL. The similarity of these two price pattern on the periods is 98.67%.
ABBV
UL
Year
ABBV Price Forecast($)
Potential Return(%)
2025
181.340
0.070
2026
220.000
19.630
2027
250.000
35.940
2028
250.000
35.940
2029
250.000
35.940
2030
250.000
35.940
AbbVie supports a strong dividend yield, which should act as valuation support, as the cash flows to support the dividend look secure over the next several years.
AbbVie's strong entrenchment in the aesthetics business (gained through the Allergan acquisition) sets up very long product cycles for several key assets like Botox based on strong brand power and physician entrenchment.
AbbVie's next generation immunology drugs targeting the IL23 and JAK pathways should help mitigate the competitive threats facing Humira over the next five years.
Wells Fargo
2025-02-03
Price Target
$195 → $210
Upside
+9.99%
Raymond James
2025-02-03
Price Target
$218 → $220
Upside
+15.23%
Truist Securities
2025-01-08
Price Target
$215 → $211
Upside
+18.66%